AstraZeneca PLC (AZN)
NYSE • Healthcare
November 18, 2026 at 21:00 UTC
Metrics Over Time
Where the Money Goes
Q3 2026In plain terms: out of every $100 in revenue, AstraZeneca PLC keeps $19 as net profit.
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings
Feb 9
in 82 daysQ1 2027% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS
AstraZeneca topped expectations on adjusted EPS while revenue came in line with consensus in the third fiscal quarter of 2026, based on preliminary results reported October 30, 2026. Revenue rose 5.3% to roughly $16.0 billion (up from about $15.2 billion a year ago); in the consensus comparison it was $15.993 billion versus a $16.003 billion estimate (-0.1%, in line). Adjusted EPS of $2.79 topped the $2.60 estimate (+7.3%) and was up from $2.38 a year ago. Profitability included gross profit of about $11.9 billion with gross margin near 75%, and operating income of roughly $4.3 billion at an operating margin of 27.0%. Net income increased 21.4% to about $3.1 billion (up from roughly $2.5 billion a year ago). AstraZeneca generated operating cash flow of roughly $4.7 billion and paid about $1.6 billion in dividends during the quarter. For the next period, consensus calls for EPS of $2.41 on revenue of $16.656 billion.
About AstraZeneca PLC
AstraZeneca PLC develops and sells prescription medicines as a large pharmaceutical company listed on the NYSE under AZN, spanning discovery, development, manufacturing, and commercialization. Its portfolio generated $58.7 billion in FY2025 revenue across treatments for cancer, cardiovascular, renal and metabolic conditions, COVID-19, and rare diseases.
Today's Snapshot
AZN closed 1.9% below yesterday's close, in line with a weaker sector. AstraZeneca extended its collaboration with Tempus AI, a healthcare-data company.
Trading Volume
Below 10d avg (2.3M)
1.8M
vs S&P 500 Today
Underperforming Market
-1.66%
Updated: November 18, 2026 at 21:07 UTC
AZN Headlines
Technical Indicators
All signalsHide signals
- EMA (5 indicators)$172.94 - $182.86Buy
- RSI (14)51.03Neutral
- Stochastic %K (14, 3, 3)38.61Neutral
- MACD Level (12, 26)4.10Neutral
Peers & Related Assets
Get premium market insights delivered directly to your inbox.